Related Experiment Video
Updated: May 23, 2026

06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Poly (ADP-ribose) transferase/polymerase-1-deficient mice resistant to age-dependent decrease in β-cell proliferation
Lei Gong1, Fu-Qiang Liu, Ying Wang
1Department of Endocrinology, Shandong University, Qilu Hospital, Jinan, Shandong, People's Republic of China.
Molecular Medicine (Cambridge, Mass.)
|April 7, 2012
Summary
Poly (adenosine diphosphate [ADP]-ribose) polymerase 1 (PARP-1) is crucial for pancreatic beta-cell regeneration in aging mice. Loss of PARP-1 enhances adaptive beta-cell proliferation in older mice, suggesting therapeutic potential.
Area of Science:
- Endocrinology
- Molecular Biology
- Aging Research
Background:
- Beta-cell regeneration capacity diminishes with age, impacting insulin production.
- The molecular mechanisms underlying age-related decline in beta-cell regeneration are not fully understood.
- Poly (ADP-ribose) polymerase 1 (PARP-1) plays a role in beta-cell function and survival.
Purpose of the Study:
- To investigate the role of PARP-1 in age-dependent beta-cell regeneration.
- To compare beta-cell regeneration capacity in young versus old wild-type (WT) and PARP-1 knockout (PARP-1⁻/⁻) mice.
- To elucidate the molecular mechanisms of PARP-1's influence on beta-cell adaptation.
Main Methods:
- Analysis of beta-cell proliferation in young (2-month-old) and old (12-month-old) WT and PARP-1⁻/⁻ mice.
- Administration of low-dose streptozotocin (STZ) to stimulate beta-cell regeneration.
- Assessment of beta-cell mass expansion and expression of regenerating (Reg) genes (RegI, RegII, RegIV).
Main Results:
- Old WT mice exhibited significantly restricted basal beta-cell proliferation compared to young WT and PARP-1⁻/⁻ mice.
- While young mice showed similar proliferation regardless of PARP-1 status, old WT mice had limited adaptive proliferation post-STZ.
- Old PARP-1⁻/⁻ mice demonstrated significantly enhanced adaptive beta-cell proliferation following STZ administration compared to old WT mice.
- Increased beta-cell mass expansion correlated with elevated RegI and RegII gene expression.
Conclusions:
- PARP-1 is a critical regulator of beta-cell regeneration capacity, particularly with advancing age.
- Loss of PARP-1 function preserves and enhances adaptive beta-cell proliferation in aged mice.
- Targeting PARP-1 may offer a novel therapeutic strategy to improve beta-cell function in aging populations.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

